Abstract: Provided are systems and methods related to calibration courses and calibration targets, which can be configured for calibrating sensors used in vehicles, such as vehicles that include autonomous or semi-autonomous vehicle systems, or other mobile robots. As an example, a system can include a drivable path comprising a plurality of turns, a plurality of calibration targets proximate to the drivable path, and a plurality of obstacles in the drivable path. The plurality of calibration targets are positioned so as to be detectable by at least one sensor of a vehicle as the vehicle traverses the drivable path, and at least one particular obstacle of the plurality of obstacles changes an angle of the at least one sensor relative to at least one calibration target as the vehicle traverses the drivable path.

Abstract: Provided are systems and methods related to calibration courses and calibration targets, which can be configured for calibrating sensors used in vehicles, such as vehicles that include autonomous or semi-autonomous vehicle systems, or other mobile robots. As an example, a system can include a drivable path comprising a plurality of turns, a plurality of calibration targets proximate to the drivable path, and a plurality of obstacles in the drivable path.

Abstract: Provided herein are methods of determining whether a subject will respond to a treatment for a neoplasia, neoplastic disorder, tumor, cancer or malignancy, the method comprising detecting the presence or amount of CDS 3 expressing cells in a biological sample from the subject, comparing the measured presence or amount to a reference presence or amount, wherein a modified measured presence or amount as compared to the reference presence or amount is indicative that the subject will or will not respond to the treatment for a neoplasia, neoplastic disorder, tumor, cancer or malignancy. Also described herein are methods of treating a neoplasia, neoplastic disorder, tumor, cancer or malignancy in a subject, the method comprising modulating CDS 3 activity or expression in a myeloid cell, or alternatively, comprising administering a population of CD33hi monocytes or CD33hi macrophages.

Abstract: Disclosed herein are apparatus, devices, and methods to provide visual analytics of GUI objects generated based on a transformation of metrics information resulting from user interaction with a platform application. The GUI objects may include map GUI objects operative to visualize metrics information within a virtual map of an application environment. The map GUI objects may be modified based on visualization requests, including, without limitation, a location and/or a time of interest or compound requests, such as a plurality of events according to a relationship. The GUI objects may include state network GUI objects to graphically depict platform application states and sequence network GUI objects to graphically depict platform application sequences as nodes within a graph.